177 related articles for article (PubMed ID: 22388834)
1. [Therapeutic apheresis in idiopathic nephrotic syndrome].
Moriconi L
G Ital Nefrol; 2012; 29 Suppl 54():S67-72. PubMed ID: 22388834
[TBL] [Abstract][Full Text] [Related]
2. Apheresis in primary focal segmental glomerulosclerosis of native and transplanted kidneys: a therapeutic protocol.
Moriconi L; Passalacqua S; Pretagostini R; Battaglia G; Russo G; De Palo T; Rindi P; Puccini R; Batini V; Carraro M; Faccini L; Artero M; Zennaro C; Cristofani R
J Nephrol; 2000; 13(5):347-51. PubMed ID: 11063138
[TBL] [Abstract][Full Text] [Related]
3. [Heterozygotic mutation in NPHS2 gene as a cause of familial steroid resistant nephrotic syndrome in two siblings--case report].
Drozdz D; Pietrzyk JA; Wierzchowska-Słowiaczek E; Sancewicz-Pach K; Antignac C; Miezyński W
Przegl Lek; 2006; 63 Suppl 3():85-6. PubMed ID: 16898497
[TBL] [Abstract][Full Text] [Related]
4. Genetic basis of nephrotic syndrome--review.
Obeidová H; Merta M; Reiterová J; Maixnerová D; Stekrová J; Rysavá R; Tesar V
Prague Med Rep; 2006; 107(1):5-16. PubMed ID: 16752799
[TBL] [Abstract][Full Text] [Related]
5. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
McCarthy ET; Sharma M; Savin VJ
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2115-21. PubMed ID: 20966123
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis of FSGS and steroid-resistant nephrosis.
Pollak MR
Semin Nephrol; 2003 Mar; 23(2):141-6. PubMed ID: 12704574
[TBL] [Abstract][Full Text] [Related]
9. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
[TBL] [Abstract][Full Text] [Related]
10. [A genetic viewpoint of focal glomerular sclerosis: fom genes to glomerular pathophysiology [corrected]].
Aucella F; Bisceglia L; Stallone C
G Ital Nefrol; 2003; 20(4):356-67. PubMed ID: 14523896
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).
Canaud G; Dion D; Zuber J; Gubler MC; Sberro R; Thervet E; Snanoudj R; Charbit M; Salomon R; Martinez F; Legendre C; Noel LH; Niaudet P
Nephrol Dial Transplant; 2010 Apr; 25(4):1321-8. PubMed ID: 19773419
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
14. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
Rodríguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
15. [Structure and function of the glomerular filtration barrier].
Musiał K; Zwolińska D
Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
[TBL] [Abstract][Full Text] [Related]
16. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
[TBL] [Abstract][Full Text] [Related]
17. [Nephrotic syndrome in childhood].
Reusz G; Szabó A; Fekete A
Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
20. Focal segmental glomerulosclerosis and renal transplantation.
Crosson JT
Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]